Tag: opioids

  • Meth Remains Greater Issue Than Opioids In Rural Minnesota

    Meth Remains Greater Issue Than Opioids In Rural Minnesota

    “In 2009 meth use shot upward and it’s been steadily climbing,” said one city official.

    While many areas of the United States are battling the opioid epidemic, parts of rural Minnesota are facing a different battle: meth

    According to the Mankato Free Press, a new study by the Center for Rural Policy and Development has found that treatment admissions for meth are increasing, as are fatalities from the drug.

    The study determined that in 2016, 7,664 people in Greater Minnesota entered treatment for meth, which was a 25% increase from 2015 and about double the amount of people seeking treatment for meth in the Twin Cities.

    “We’ve been bombarded with the news of all the deaths from opioids. Our job is to find out what may be the same or different in Greater Minnesota than in the Twin Cities,” Marnie Werner, interim executive director of the Center for Rural Policy and Development, told the Mankato Free Press. “As soon as we started talking to a few county administrators, we found that opioids are a problem, but meth is a bigger problem.”

    According to Werner, the state as a whole appears to have a large issue with opioids due to the size of the Twin Cities. “The Twin Cities is so large it skews the statewide data,” she said. 

    For Blue Earth County Attorney Pat McDermott, the report’s findings were not new information.

    “Meth continues to be the drug of choice and probably the primary controlled substance we deal with and the drug task force deals with,” he told the Mankato Free Press. “Meth crimes are what’s driving our numbers and the drug task force’s numbers. There are five times as many meth cases than cocaine… (and) four times more meth cases than prescription cases.”

    While Werner says that meth use dropped in the early 2000s—when it became required that pseudoephedrine cold medicines, often used to make meth, be sold behind pharmacy counters and be limited in quantity. However, she says, meth manufacturing then picked up in Mexico and entered the U.S.

    “In 2009 meth use shot upward and it’s been steadily climbing,” Werner told the Free Press. “The way it’s being mass produced, prices have dropped and it’s very affordable to people. So these people who have underlying addiction or mental health problems who maybe couldn’t afford drugs before can now.” 

    Blue Earth County has some initiatives in place to help combat drug issues, such as the Yellow Line Project, which allows first-time offenders to seek treatment rather than go to jail. 

    “If you get them connected to services sooner rather than later, you’re better off. If you put someone in prison for three years, they’re going to come out with the same mindset they had,” McDermott told the Free Press.

    View the original article at thefix.com

  • Should You Breastfeed Your Baby If You're on Methadone?

    Should You Breastfeed Your Baby If You're on Methadone?

    My daughter was born with neonatal abstinence syndrome but I was not allowed to nurse or have her in the room with me; the hospital staff said the methadone in my breast milk could be dangerous. They were wrong.

    Earlier this summer several news outlets reported on the death of an 11-week-old infant in Philadelphia by what appeared to be a drug overdose. The mother, who has been charged with criminal homicide, blamed the drug exposure on her breast milk. Although an autopsy revealed that the infant’s drug exposure also included amphetamine and methamphetamine, many news outlets chose to focus on the fact that the mother was a methadone patient. The death of an infant by drug exposure is unquestionably terrible; unfortunately, misleading articles make what is already a tragedy even worse by insinuating or directly stating that the methadone content in the breast milk was involved in the infant’s death.

    Stigma around methadone use in the United States has a long shadow. Prescribed primarily to treat opioid use disorder (but also sometimes for pain management), methadone is a long acting opioid that builds in the patient’s bloodstream to create a stable, non-euphoric equilibrium when used correctly. It is a highly effective form of both addiction treatment and harm reduction, shown to reduce overdose deaths by 50% or more. Unlike short acting opioids like heroin or morphine, methadone prevents patients from experiencing the physical chaos of sedation and withdrawal, and can help re-balance neurochemical changes that take place during active addiction. For decades, methadone has been considered the gold standard of treatment for opioid use disorder, including during and after pregnancy.

    But in spite of the demonstrated benefits of methadone and its pharmacological differences from commonly misused opioids, it has, for many years, acquired a popular status as “legal heroin.” Social media is flooded with memes mocking methadone patients or complaining that they don’t deserve “free methadone” when other drugs cost money (in fact, methadone has a price tag like any other medication). Even other people in recovery or the throes of active addiction disparage methadone, sometimes referring to it as “liquid handcuffs” because of the stringent regulations requiring daily trips to a clinic during the first several months of treatment.

    This stigma leaks into every aspect of patient care. For me, it prevented me from seeking treatment for years. I was terrified to get on methadone. Who would volunteer to be “handcuffed” by a treatment system? But when I learned I was pregnant, my doctors urged me to get on methadone. They said that attempting to withdraw from heroin would be dangerous for my developing baby, and continuing to use would be even riskier.

    I was reluctant, but I enrolled in a methadone maintenance program as my doctors advised. Because of that, I had a healthy, full-term pregnancy. But at the Florida-based hospital where my daughter was taken after a speedy, unplanned home birth, I was not allowed to breastfeed. My daughter suffered neonatal abstinence syndrome (NAS), a condition caused by opioid withdrawal that occurs in some babies whose mothers used methadone or other opioids while pregnant; she was dosed with morphine to wean her down from the methadone she received in utero, and the hospital staff told me that adding my methadone dose via breast milk could be dangerous. Because of that, my milk production dwindled, and my daughter—who stayed in the hospital over a month—never learned to properly latch. After she came home, she suffered colic, constipation, and sleep disturbances as we worked through various formulas trying to find one that was gentle on her stomach.

    But these negative ideas about methadone distribution in breast milk are flat out wrong. We know that methadone is a highly potent, long-acting opioid that is extremely dangerous if given to infants and children directly. No amount of methadone syrup should be administered to an infant or child by a parent or caregiver without physician approval. But studies have demonstrated that the amount of methadone that gets passed into breast milk is negligible, and will not harm an infant, even a newborn. A 2007 study of methadone-maintained mothers in addiction recovery found that methadone concentrations in breast milk remained minimal in the first four days postpartum, regardless of maternal dose, time of day after dosing, and type of breast milk being expressed. The daily amount of methadone ingestible by the infants did not rise above .09 mg per day. To help prevent even that slight fluctuation, John McCarthy, a practicing and teaching psychiatrist who has treated opioid-dependent pregnant and postpartum women for over 40 years, suggests splitting nursing mothers’ methadone doses in two—a measure that should have begun during pregnancy to help minimize the risk of NAS. “It’s not dangerous to nurse on a once a day dose, but it’s not the best way to give the medication. The baby should be given a smooth level of methadone.”

    Some people believe that breastfeeding an infant with NAS while on methadone will help decrease withdrawal symptoms by providing a minute amount of the same drug from which the infant is withdrawing. According to experts like Jana Burson, a doctor specializing in the treatment of opioid addiction, this belief is also false: “some mothers erroneously think their babies won’t withdraw if they breastfeed—that’s wrong. There’s not enough methadone in the breast milk to treat NAS.” Of course, breastfeeding a child who experiences NAS is beneficial, both because of the health benefits of breast milk, and because maternal contact is important for babies in distress. “Breastfeeding will help in the general sense that babies like to breastfeed and it’s calming, but not because babies are getting methadone in the breast milk.”

    Sandi C., a methadone-maintained mother based out of Massachusetts, breastfed her son for two and a half years, and plans on breastfeeding the baby she is currently expecting. Like me, Sandi was addicted to heroin when she learned she was pregnant. She began on buprenorphine, a partial-opioid agonist used similarly to methadone, and switched to methadone partway through her pregnancy. But her postnatal experience was different than mine.

    “I’m really fortunate that my area is really encouraging of breastfeeding,” says Sandi. “Actually, I wasn’t sure if I could breastfeed and [my doctor] said ‘definitely breastfeed, we encourage it.’” Like my daughter, Sandi’s son was diagnosed with NAS. But instead of being sent to the Neonatal Intensive Care Unit (NICU), her son was allowed to be in the hospital room with her, where Sandi could hold and breastfeed him as much as he needed. Her son was released after just two weeks, less than half the time my daughter spent in the NICU at our hospital in Florida. She continued to breastfeed at home until he was over two years old.

    “He never got sedated,” she recalls. “Everything was fine.”

    Just because methadone is safe for breastfeeding moms doesn’t mean the same is true for other drugs. If the Philadelphia baby’s death was in fact caused by what many outlets have called “drug-laced breast milk,” it would have been due to the amphetamines, not the methadone. Methamphetamine breast milk exposure has not been studied as extensively as methadone, but current recommendations are that lactating women should wait 48 hours after their last use of methamphetamine before resuming breastfeeding. Experts like Burson and McCarthy agree that mothers on methadone maintenance who are not using other substances can safely breastfeed. “All of the major medical groups recommend it,” Burson said, adding, “even on higher doses they all recommend that mothers on methadone breastfeed.”

    View the original article at thefix.com

  • Can Ketamine Use Trigger Opioid-Like Dependency?

    Can Ketamine Use Trigger Opioid-Like Dependency?

    Researchers investigated whether ketamine works on depression by acting like an opioid in the brain.

    Though ketamine has gained the support of some mental health professionals as a possible therapy for depression, a new study suggests that the drug’s anti-depressive qualities may also have a hidden and potentially dangerous side effect: ketamine may offer relief from depressive symptoms by activating the body’s opioid system, which in turn may make some users dependent upon it, like an opioid.

    In an editorial that accompanied the study, Dr. Mark George, professor of psychiatry, radiology and neuroscience at the Medical University of South Carolina, wrote, “We would hate to treat the depression and suicide epidemics by overusing ketamine, which might unintentionally grow the third head of opioid dependence.”

    The study, conducted by researchers from Stanford University and published in the August 2018 edition of the American Journal of Psychiatry, was comprised of a double-blind crossover of 30 adults with treatment-resistant depression, which was defined as having tried at least four antidepressants and receiving no benefit from them.

    The authors looked at 14 of the patients—of which 12 had received, in randomized order, two doses of 0.5 mg of ketamine—once after receiving 50 mg of naltrexone (or Vivitrol) which blocks the brain’s opiate receptors and diminishes cravings for opioids; and once after receiving a placebo instead of the naltrexone—with the injections occurring about a month apart. 

    The goal of the study was to determine whether the naltrexone and ketamine combination would reduce the latter drug’s antidepressant qualities, or its dissociative or opioid-like response.

    The authors’ analysis found that when patients received the placebo/ketamine combination, they experienced what Live Science called a “dramatic reduction” of their depressive symptoms. But the naltrexone/ketamine combination appeared to have no effect on their symptoms.

    Additionally, those participants who received naltrexone experienced the dissociative effects of ketamine, which include hallucinations, which prompted the authors to cut the study short to avoid exposing more participants to a “clearly ineffective and noxious combination treatment,” as the study noted.

    The scope of the study was small, and as George (who was not involved in the study) noted, additional research is required in order to determine if the ketamine’s antidepressant qualities are caused by its impact on opioid receptors or another receptor. He ultimately expressed caution in regard to using ketamine for the treatment of depression.

    “Ketamine clinics that do not focus on accurate diagnosis, use proper symptom rating instruments and discuss long-term treatment options are likely not in patients’ best interests,” he wrote in the editorial. “We need to better understand ketamine’s mode of action and how it should be used and administered.”

    View the original article at thefix.com

  • Stop Illegally Selling Opioids Online, FDA Warns

    Stop Illegally Selling Opioids Online, FDA Warns

    Over the summer, the FDA has issued similar warnings to 70 websites. 

    The Food and Drug Administration issued a warning this week to the operators of 21 websites that the administration says sell mislabeled and illegal opioids to Americans. 

    The websites, which are run by four companies, have been “illegally marketing potentially dangerous, unapproved, and misbranded versions of opioid medications, including tramadol,” according to a press release issued by the FDA on Tuesday (August 28). 

    “The illegal online sale of opioids represents a serious risk to Americans and is helping to fuel the opioid crisis. Cutting off this flow of illicit internet traffic in opioids is critical, and we’ll continue to pursue all means of enforcement to hinder online drug dealers and curb this dangerous practice,” FDA Commissioner Scott Gottlieb said in the news release.

    Over the summer, the FDA has issued similar warnings to 70 websites. 

    “The FDA remains resolute in our promise to continue cracking down on these networks to protect the public health,” Gottlieb said. “We have more operations underway, and additional actions planned. We are also working closely with legitimate Internet stakeholders, including leading social media sites, in these public health efforts.”

    People who buy their opioids online can often wind up with expired, counterfeit or contaminated pills, according to the FDA. Some of the pills are marketed under one name, but are really just pressed fentanyl, a dangerous synthetic opioid. On CNBC’s Squawk Box, Gottlieb said that online sales are making the ongoing opioid crisis worse.

    “As we see doctors prescribe fewer opioids, we’re fearful that more and more of the new addiction is going to shift to illicit sources, and a lot of those illicit sales are taking place online,” he said on Tuesday.

    The four companies that received warnings on Tuesday were CoinRX, MedInc.biz, PharmacyAffiliates.org and PharmaMedics. They have 10 days to respond to the FDA’s letter, outlining the specific actions that they will take to avoid selling illegal opioids to Americans. If the companies do not respond they may face legal action. 

    On Wednesday, Gottlieb said that the FDA will continue to aggressively pursue companies and practices that make opioids too easily available. 

    “The reason that we find ourselves with a crisis of such proportion is that as a medical profession, we’ve been one step behind its sinister advance,” he said in a press release.

    “Collectively, we didn’t take all the steps we could, when we could, to stop the advance of this crisis. We shunned hard decisions. As a profession, providers were too liberal in our use of these drugs well past the point where there were signs of trouble, and the beginning of a crisis of addiction. I’m committed to making sure that we don’t perpetuate these mistakes of the past. And so, when we see this crisis taking new twists and turns, we’ve acted swiftly.”

    View the original article at thefix.com

  • Fentanyl Present In 90% Of Drugs, Massachusetts Officials Warn

    Fentanyl Present In 90% Of Drugs, Massachusetts Officials Warn

    The synthetic opioid is found more in combination with cocaine and benzodiazepines than heroin.

    Officials in Massachusetts are warning the public that the presence of the deadly synthetic opioid, fentanyl, is increasingly common in all types of illicit drugs in the state—not just in heroin or other opioids—raising the overdose risk for users of cocaine and other illegal substances. 

    “If an individual is using illicit drugs in Massachusetts, there’s a very high likelihood that fentanyl, which is so deadly, could be present,” said Dr. Monica Bharel, commissioner of the state Department of Public Health, according to New England Public Radio. “Anybody using illicit drugs should understand the risks, carry naloxone, and access treatment.”

    The state’s quarterly report found that fentanyl is present in 90% of overdose deaths in Massachusetts. It is found more in combination with cocaine and benzodiazepines than with heroin. In 2014, fentanyl was found in less than 30% of overdose deaths in the Bay State. 

    Because fentanyl is becoming more prevalent in cocaine and benzodiazepines, officials are advising family members of people who use illicit drugs to carry naloxone, the opioid overdose reversal drug. People who do not use opioids regularly are more susceptible to fentanyl overdose because they have not built up an opioid tolerance. 

    Because of this, the state is urging healthcare providers to help all drug users get into treatment, not just those who report that their primary drug of choice is an opioid. 

    “When analyzing opioid overdose deaths, we have become aware that a significant portion of the deaths are associated with concurrent cocaine use,” the state wrote in a letter to providers. “We believe this information is useful for you in your clinical work. Additionally, patients should be aware that polysubstance use can NOT be a reason for refusal for admission in the treatment system.” 

    The report also showed that overdose deaths are declining in Massachusetts for the third straight quarter, even as such deaths continue to rise nationally. This could be due in part to the rising rates at which EMTs in the state are administering naloxone, as well as public health campaigns, Bharel said. 

    “In Massachusetts we have a multi-pronged approach,” she said. “This is about prevention, raising awareness in our communities, and raising awareness among our prescribers.” 

    However, not all demographics are seeing the improvement. Hispanics are disproportionately likely to die of an overdose in Massachusetts, and the overdose rates for black men continue to rise. 

    “While the results of our efforts are having an impact, we must double down on our efforts to implement treatment strategies that meet the needs of the highest risk individuals and communities,” Health and Human Services Secretary Marylou Sudders said in a statement.

    View the original article at thefix.com

  • Inside Racial Disparities In Opioid Prescribing, Drug Testing

    Inside Racial Disparities In Opioid Prescribing, Drug Testing

    Black patients who tested positive for marijuana were twice as likely to have their pain pills discontinued than their white counterparts.

    Black patients who are prescribed opioids for chronic pain are more likely to be tested for illicit drug use than their white counterparts.

    Black patients are also more likely to have their pain medication discontinued if they test positive for other substances, including marijuana, according to new research. 

    The research, conducted at Yale, analyzed the health records of 15,000 patients Veterans Administration between 2000 and 2010. The Centers for Disease Control and Prevention recommends testing patients who get opioids for illicit drug use, but the researchers found that doctors rarely enforce the policy.

    However, when the drug-testing policy was enforced it was more likely to be applied to black patients. 

    In addition, black patients were more likely to have their opioid prescriptions discontinued if they tested positive for marijuana or cocaine. Ninety percent of people who tested positive for illicit substances kept their opioid prescriptions, but blacks were twice as likely to have their pain pills taken away. 

    “If they were black and tested positive for marijuana, they were twice as likely to have opioids discontinued, and for cocaine, they were three times more likely,” Julie Gaither, lead study author, told Science Daily

    Gaither blames this on lack of consistent policy and engrained biases. 

    “There is no mandate to immediately stop a patient from taking prescription opioids if they test positive for illicit drugs,” Gaither said. “It’s our feeling that without clear guidance, physicians are falling back on ingrained stereotypes, including racial stereotyping. When faced with evidence of illicit drug use, clinicians are more likely to discontinue opioids when a patient is black, even though research has shown that whites are the group at highest risk for overdose and death.”

    Having an established protocol for what to do when a patient tests positive for illicit substance could help address biases, Gaither said. 

    “This study underscores the urgent need for a more universal approach to monitoring patients prescribed opioids for the concurrent use of sedatives and other substances that may increase the risk of overdose,” she said. 

    However, even with a policy in place, minorities may still face discrimination when it comes to drug testing, something many black Americans experience regularly.

    In July, tennis great Serena Williams tweeted her frustration at being tested for drugs more than twice as often as her competitors. 

    “It’s that time of the day to get ‘randomly’ drug tested and only test Serena. Out of all the players it’s been proven I’m the one getting tested the most. Discrimination? I think so,” she wrote. 

    View the original article at thefix.com

  • Iceland May Be On The Verge Of Opioid Epidemic Similar To The US

    Iceland May Be On The Verge Of Opioid Epidemic Similar To The US

    In 2017, there was about one drug-related death per 10,000 people in Iceland, compared to one per 4,500 in the US. 

    During the first half of this year, Iceland has already seen 29 likely drug overdose deaths—nearly as many as the 32 total that the country had in 2017. 

    The alarming increase, according to Reykjavík Grapevine magazine, could be due to a developing crisis in the country. 

    Ólafur B. Einarsson of the Directorate Of Health—a government agency under Iceland’s Ministry of Welfare—tells the Grapevine that substances like amphetamine and cocaine have been discovered in various samples from those who have died, though those substances have not been determined to be the cause of death. 

    “There have been 29 deaths that are probably related to drugs from January to the middle of June this year,” Einarsson said. “But it remains to be confirmed whether they are all directly linked to drugs.” 

    Einarsson added that cocaine has been discovered in five of the deaths, which is “a lot.” However, he says, a bigger concern is the abuse of prescription drugs in the country. 

    “Compared to other Nordic countries, Iceland has a 30% higher consumption rate of nervous system medication like oxycodone,” Einarsson says. 

    Because of this statistic, the Grapevine notes, the Directorate Of Health in Iceland began an online prescription database in 2016 with the hope that it would prevent physicians from prescribing numerous medications to the same patient. 

    According to Einarsson, another alarming trend lies in the ages of those abusing drugs. “This year, we discovered that more young people consumed a mix of strong opioid analgesics and cannabis or alcohol,” Einarsson told the Grapevine

    According to Einarsson, the group most at risk is young men. In fact, 79% of those dead in 2018 were males. 

    While the specific numbers don’t touch the United States in terms of quantity, the per capita ratio does. Iceland is home to only 338,000 people, while the U.S. has a population of more than 326,000,000.

    According to the Grapevine, there was about one drug-related death per 10,000 people in Iceland last year, compared to one per 4,500 in the U.S. 

    “In my opinion, the current situation is a crisis and if the numbers will continue to rise this year, we will in fact be very close to the figures of the United States, proportionally speaking,” Einarsson said. 

    The drug-related deaths reflect a larger problem in Iceland.  

    “Overall, there’s a lot more going on than drug-related deaths,” Einarsson told the Grapevine. “This is the darkest part of the whole picture and there are hundreds of people who are admitted to the hospitals every year due to drug overuse. There have been questions about the healthcare system and how to improve it for several years now.”

    View the original article at thefix.com

  • Dopesick: An Interview with Beth Macy

    Dopesick: An Interview with Beth Macy

    It takes the average user eight years and five to six treatment attempts just to achieve one year of sobriety. And in an era of fentanyl and other even stronger synthetic opioids, many users don’t have eight years.

    As recently as a few years ago, the opioid crisis could be referred to as a “silent epidemic,” perhaps in part due to its degrading nature. Opioid addiction is frequently described using metaphors of slavery, or enslavement, and those within its clutches are liable to feel acutely ashamed. No longer, however, is it possible to argue that the scourge of opioid addiction is being overlooked.

    No doubt that is partly due to the growing enormity of the problem. For each of the past several years, more people have died from drug overdoses than American service members were killed during the entire Vietnam War.

    Meanwhile, energetic and compassionate journalists have been doing outstanding work, covering the crisis from various vantages. Chief among them is Beth Macy, a New York Times-bestselling author, who first began noticing the effects of opioid addiction as a reporter for the Roanoke Times, where she worked for 25 years until 2014. Now she is out with Dopesick: Dealers, Doctors, and the Drug Company That Addicted America. Gracefully written and deeply reported, Dopesick should act as a vade mecum — a handbook, a guide, an essential introduction — for anyone who may be seeking insight into the deadliest and most vexing drug epidemic in American history. 

    Beth spoke to The Fix over email:

    The Fix: The first chapters of your book, on the origins of the opioid crisis, cover some material that others have explored (most notably Barry Meier, in Pain Killer: An Empire of Deceit and the Origin of America’s Opioid Epidemic). Still, I don’t have the sense that many people are aware of the role that Purdue Pharma played in setting off current epidemic. Briefly, what is their culpability? And why do think their crimes aren’t crimes better known? 

    Beth Macy: I think Meier’s book, Pain Killer, was too early, initially published in 2003, and it was largely set in central Appalachia — a politically unimportant place. Also, let’s not overlook the role that Purdue took in stifling Meier. As I write in the book, company officials had him removed from the beat after his book came out, arguing that he now had a financial stake in making Purdue look bad.

    After the 2007 plea agreement, in which the company’s holding company, Purdue Frederick, pled guilty to criminal misbranding charges and its top three executives to misdemeanor versions of that crime, Purdue and other opioid makers and distributors spent 900 million dollars on political lobbying and campaigns. Purdue continued selling the original OxyContin formula until it was reformulated to be abuse-resistant in 2010, continued for years after that pushing the motion that untreated pain was really the epidemic that Americans should be concerned about. Their culpability in seeding this epidemic is huge.

    You weren’t able to talk directly with any of the Purdue executives who made fortunes from OxyContin, and who criminally misled the public about its addictive potential. But you spent an afternoon interviewing Ronnie Jones, who is currently serving a lengthy prison sentence for running a major heroin distribution operation in West Virginia. How were Jones’s crimes (and his rationalizations for his behavior) different from those of the Purdue executives you wrote about?

    Great question. Jones refused to see that he brought bulk heroin to a rural community in ways that overwhelmed families and first responders in the region with heroin addiction; he told me he believed he was providing a service — his heroin did not have fentanyl in it, he argued, and it was cheaper than when people ran up the heroin highway to get it in Baltimore (and safer because they could stay out of high-crime places).

    At the 2007 sentencing hearing, Purdue executives and their lawyers repeatedly claimed they had no knowledge of crimes that were happening several rungs down the ladder from them; that the government had not proved their culpability in the specific crimes. According to new Justice Department documents unearthed and recently published by The New York Times , that was simply not true. For two decades, Purdue leaders blamed the users for misusing their drug; they refused to accept responsibility for criminal misbranding that resulted in widespread addiction and waves of drug-fueled crime that will be felt in communities and families for generations to come.

    You quote a health care professional who said that previous drug epidemics began waning after enough people finally got the message: “Don’t mess with this shit, not even a little bit.” That provoked a thought: Shouldn’t we be long past this point with opioids? On the one hand, I’m enormously sympathetic to anyone who is struggling with addiction. But it’s frustrating to realize that the opioid crisis is still building. Why aren’t more people as risk-averse about heroin as they obviously should be?

    The crisis is still building because the government’s response to it has largely been impotent. And it’s been festering for two decades. Opioid addiction doesn’t just go away. It takes the average user eight years and five to six treatment attempts just to achieve one year of sobriety. And in an era of fentanyl and other even stronger synthetic opioids, many users don’t have eight years. I hope we will soon get to the point of public education where no young person “messes with this shit, not even once,” but right now we still have 2.6 million people with opioid use disorder. Even though physicians have begun prescribing less, we still have all these addicted people who should be seen as patients worthy of medical care, not simply criminals. Too often that doesn’t happen until we’re sitting in their funeral pews.

    One of the women you write about, Tess Henry, slid down a long road. You got to know her and her family quite well, over a number of years. And some of the other stories in this book are just as heartbreaking.

    It was a lot of pain to absorb and process, yes. And yet my heartache was nothing at all compared to what these families are going through.

    In a couple instances, Tess reached out to you directly, asking you for help. How did you calculate how to respond?

    I took it case by case; I just went with my gut, and I got input from my husband and trusted friends along the way. I decided it was okay to drive Tess around to [Narcotics Anonymous] meetings, recording our interviews as I drove, with her permission. But it wasn’t okay when she texted me late one night to come get her from a drug house. (I referred her plea to her mother and recovery coach instead.)

    I occasionally gave her mother unsolicited advice because I cared about her and I cared about Tess, and I felt I had access to objective information about medication-assisted treatment that Patricia didn’t have. When Tess was murdered on Christmas Eve, I put my notes away and for several days just focused on being a friend to her mom. But I did accompany the family to the funeral home when they made arrangements (taking occasional notes), and I was there in the room of the funeral parlor with her mom and her grandfather when they said goodbye to her. It took funeral technicians two days to prepare her body for that. It was the most heartbreaking scene I’ve ever witnessed. There was no need to take notes in that moment. I will never forget it as long as I live. I said a tearful goodbye to our poet, too.

    Was there ever a risk, over the course of your reporting, of becoming too involved in the lives and predicaments of the people you were writing about? 

    Always there’s a risk, but I’ve been doing this for more than 30 years now, and I know that my greatest skill — which is that I get close to people — can also be my Achilles. When I trust my gut and try to do the right thing — always also getting advice from editor and reporter friends along the way, including my husband, who is just so smart and so spot-on always — it usually works out.

    I’m grateful to have read Dopesick. But at various times it left me infuriated, appalled, and depressed. Can you leave us with anything to be hopeful about? 

    There are some pretty heartening grassroots efforts that I spotlight at the book’s end, mostly involving providing access to treatment and harm-reduction services. And Virginia just became the 33rd state to approve Medicaid under the Affordable Care Act, which will help 300,000 to 400,000 people in the commonwealth have access to substance use disorder services. Seventeen more states to go! There is so much more work to be done, especially in Appalachia, where overdose deaths are highest and resistance to harm reduction programs (easy-access MAT and syringe exchange and recovery) can be severe. My goal is that Dopesick not only educates people but also mobilizes them to care and create what Tess Henry called “urgent care for the addicted” services in their own hometowns.

    View the original article at thefix.com

  • Prince’s Family Sues Doctor Who Reportedly Prescribed Him Pain Pills

    Prince’s Family Sues Doctor Who Reportedly Prescribed Him Pain Pills

    The lawsuit alleges that the doctor had to treat Prince’s opioid addiction prior to do his death but “failed to do so.”

    The family of Prince (born Prince Rogers Nelson) is suing a doctor accused of playing a “substantial part” in the music icon’s death.

    According to the Midwest Medical Examiner’s Office, the official cause of Prince’s April 15, 2016 death was an accidental overdose of fentanyl.

    The family is suing Dr. Michael Schulenberg in Hennepin County District Court in Minnesota, to replace the lawsuit filed in April in Illinois, according to the family’s attorney.

    The lawsuit alleges that Schulenberg and others—including the hospital where Schulenberg was working at the time)—had “an opportunity and duty during the weeks before Prince’s death to diagnose and treat Prince’s opioid addiction, and to prevent his death.” However, the family states, “They failed to do so.”

    The lawsuit seeks unspecified damages in excess of $50,000, ABC News reports.

    Authorities say the doctor admitted to prescribing oxycodone a week before his death, under his bodyguard’s name to protect his privacy.

    However, Schulenberg’s lawyer, Amy S. Conners, said in a statement that the doctor “never directly prescribed opioids to Prince, nor did he ever prescribe opioids to any other person with the intent that they would be given to Prince,” the New York Times reported in April 2017.

    Investigators later stated that it was possible that Prince was not aware that the medication he was taking contained fentanyl.

    “In all likelihood, Prince had no idea he was taking a counterfeit pill that could kill him,” said Carver County Attorney Mark Metz this past April, while announcing that no criminal charges would be filed in the musician’s death. “Others around Prince also likely did not know that the pills were counterfeit containing fentanyl.”

    Many of the medications found in the musician’s home were not in the original container provided by the pharmacy. “The evidence demonstrates that Prince thought he was taking Vicodin and not fentanyl,” Metz stated. “The evidence suggest that Prince had long suffered significant pain, became addicted to pain medications but took efforts to protect his privacy.”

    Walgreens Co., where some of the prescriptions were filled, is also named in the family’s lawsuit.

    Schulenberg’s attorney Paul Peterson maintained that the doctor did everything he could for the musician. “We understand this situation has been difficult on everyone close to Mr. Nelson and his fans across the globe,” said Peterson. “Be that as it may, Dr. Schulenberg stands behind the care that Mr. Nelson received. We intend to defend this case.”

    View the original article at thefix.com

  • Woman Reportedly Caught With 1.5 Million Lethal Doses Of Fentanyl

    Woman Reportedly Caught With 1.5 Million Lethal Doses Of Fentanyl

    A woman traveling from Los Angeles to New York City was reportedly caught with five pounds of fentanyl in a suitcase.

    Authorities in Kansas City arrested a woman at a bus station who was traveling across the country, from Los Angeles to New York, carrying five pounds of fentanyl—reportedly enough of the drug to cause 1.5 million lethal overdoses.

    Kansas City Police noticed 33-year-old Evelyn C. Sanchez was “intently watching” detectives as they searched through the luggage on the bus.

    When asked, Sanchez told authorities she was heading to New York for “maybe a week,” but the story fell apart when officers reportedly noticed she had not packed a lot of clothing in her luggage.

    Following her questioning, K-9 units sniffed inside the bus and indicated a suitcase near Sanchez’s seat on the bus. When the other bus passengers did not claim the suitcase as theirs, police asked Sanchez and she admitted it was hers before allowing officers to search it.

    Authorities noted that she seemed “very nervous.”

    When asked, Sanchez told police she had “drugs,” according to court records. She did not seem to know what exactly she had, “but it’s a lot.”

    Officers checked inside and did indeed find a lot of drugs—over five pounds of fentanyl, “capable of killing thousands of people,” according to Kansas City Police Chief Rick Smith.

    Local authorities cooperated with the Drug Enforcement Administration (DEA) in the investigation. The DEA estimates the amount of fentanyl could kill several orders of magnitude more people than Smith’s estimates, claiming the operation took “1.5 million lethal doses from the streets.”

    There’s no telling where the fentanyl was ultimately heading yet, but it was almost guaranteed to help drive up the number of overdose deaths in the United States and further exacerbate the impact of the opioid crisis.

    Of 72,000 overdose deaths in 2017, 50,000 of those were opioid-related—30,000 of which were from fentanyl or related synthetic opioids.

    The drug is even getting to people who don’t want them—of 907 samples of drugs sold as heroin in Vancouver, Canada, 822 contained fentanyl.

    The U.S. Attorney’s office says Sanchez is in federal custody and awaiting a court date to be scheduled.

    View the original article at thefix.com